Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Dec;20(12):1717-22.
doi: 10.1517/13543784.2011.630660. Epub 2011 Oct 24.

Potential use of exenatide for the treatment of obesity

Franco Folli  1 , Rodolfo Guardado Mendoza
Affiliations
Review

Potential use of exenatide for the treatment of obesity

Franco Folli et al. Expert Opin Investig Drugs. 2011 Dec.

Abstract

Introduction: Obesity is a major health threat in the Western world because of its high incidence and prevalence, and its association with metabolic and cardiovascular disease as well as cancer. The reduction of food intake in obese patients can be achieved only transiently (generally for no longer than 6 months), in the absence of concomitant pharmacological therapy. Only bariatric surgery provides a means to increase satiety and/or decrease nutrient absorption in obese patients, in the long term.

Areas covered: This article reviews the available pharmacological treatments for obesity as well as the pharmacology and mechanism of action of exenatide in obese type 2 diabetic patients.

Expert opinion: Exenatide is a potential new candidate treatment for obesity, possibly in combination with other hormones that increase satiety (leptin) and slow gastric emptying (amylin).

PubMed Disclaimer

Conflict of interest statement

Declaration of interest:

The authors state no conflict of interest and have received no payment in preparation of this manuscript.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008 Jul 17;359(3):229–41. - PubMed
    1. Eckel RH. Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med. 2008 May 1;358(18):1941–50. - PubMed
    1. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010 Sep 2;363(10):905–17. (This is a clinical trial that evaluated the cardiovascular effects of sibutramine in patients with and without preexisting cardiovascular disease) - PubMed
    1. Wright SM, Aronne LJ. Obesity in 2010: the future of obesity medicine: where do we go from here? Nat Rev Endocrinol. 2011 Feb;7(2):69–70. - PubMed
    1. Powell AG, Apovian CM, Aronne LJ. New drug targets for the treatment of obesity. Clin Pharmacol Ther. 2011 Jul;90(1):40–51. - PubMed

Publication types

MeSH terms